Non-equivalence of digoxin tablets in the U.K. and its clinical implications.
作者信息
Shaw T R
出版信息
Postgrad Med J. 1974 Nov;50 Suppl 6:24-9.
PMID:4459884
Abstract
摘要
相似文献
1
Non-equivalence of digoxin tablets in the U.K. and its clinical implications.英国地高辛片剂的非等效性及其临床意义。
Postgrad Med J. 1974 Nov;50 Suppl 6:24-9.
2
The dissolution rate of digoxin tablets on the U.K. market: the scale of the problem.英国市场上地高辛片剂的溶出率：问题的规模。
Postgrad Med J. 1974 Nov;50 Suppl 6:52-5.
3
Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.英国地高辛片剂的治疗不等效性：与片剂溶出率的相关性。
Br Med J. 1973 Dec 29;4(5895):763-6. doi: 10.1136/bmj.4.5895.763.
4
Quality control of digoxin tablets.地高辛片的质量控制
Postgrad Med J. 1974 Nov;50 Suppl 6:37-40.
5
Physical and dissolution characteristics and bio-availability of five brands of digoxin tablets.五种品牌地高辛片的物理和溶出特性及生物利用度
S Afr Med J. 1980 Apr 5;57(14):530-3.
6
Recognition of variable bioavailability as an international problem: a review of the earlier studies.将生物利用度的变异性视为一个国际问题：早期研究综述。
Postgrad Med J. 1974 Nov;50 Suppl 6:14-8.
7
In vitro characterisation of digoxin tablets marketed in India.印度市场上销售的地高辛片剂的体外特性研究。
Indian J Med Res. 1983 Mar;77:395-400.
8
Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
Int J Clin Pharmacol Ther Toxicol. 1986 Jan;24(1):30-3.
9
Letter: Discrepancy between solution and bioavailability of digoxin tablets.信函：地高辛片溶液与生物利用度之间的差异
Lancet. 1975 Mar 15;1(7907):629. doi: 10.1016/s0140-6736(75)91907-8.
10
Dissolution studies with single tablets of digoxin B.P.地高辛英国药典单片溶出度研究
Postgrad Med J. 1974 Nov;50 Suppl 6:43-7.
引用本文的文献
1
Bioavailability of drugs: the digoxin dilemma.药物的生物利用度：地高辛的困境。
Clin Pharmacokinet. 1976;1(1):36-51. doi: 10.2165/00003088-197601010-00004.
Zotero 插件